Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
about
Biomarkers for assessing disease activity in inflammatory bowel diseaseDanish cohort of monozygotic inflammatory bowel disease twins: Clinical characteristics and inflammatory activityFecal calprotectin in inflammatory bowel diseaseEmerging role of novel biomarkers in the diagnosis of inflammatory bowel diseaseFaecal calprotectin: Management in inflammatory bowel diseaseThe role of calprotectin in pediatric diseaseEvaluation of inflammatory activity in Crohn's disease and ulcerative colitisOptimising monitoring in the management of Crohn's disease: a physician's perspectiveDiagnostic accuracy of fecal lactoferrin for inflammatory bowel disease: a meta-analysisClinicians' guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel diseaseComparisons between myeloperoxidase, lactoferrin, calprotectin and lipocalin-2, as fecal biomarkers of intestinal inflammation in malnourished children.Diagnostic yield of endoscopy in patients with abdominal complaints: incremental value of faecal calprotectin on guidelines of appropriateness.Frequency of abnormal fecal biomarkers in irritable bowel syndrome.Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The IMMINENT Study.Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease.Biomarkers of inflammatory bowel disease.Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study.Genetic and functional profiling of Crohn's disease: autophagy mechanism and susceptibility to infectious diseasesValue of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study.The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis.Fecal calprotectin levels are higher in rural than in urban Chinese infants and negatively associated with growthThe role of faecal calprotectin in the differentiation of organic from functional bowel disorders.The role and utility of faecal markers in inflammatory bowel disease.Challenges in diagnostic accuracy studies in primary care: the fecal calprotectin exampleAre IBD patients more likely to have a prior diagnosis of irritable bowel syndrome? Report of a case-control study in the General Practice Research Database.Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?Changes in gene expression in human meibomian gland dysfunction.Crohn's disease after gastric bypass surgery.Is faecal calprotectin equally useful in all Crohn's disease locations? A prospective, comparative study.Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome.Associations among Inflammatory Biomarkers in the Circulating, Plasmatic, Salivary and Intraluminal Anatomical Compartments in Apparently Healthy Preschool Children from the Western Highlands of Guatemala.Geophagy is associated with environmental enteropathy and stunting in children in rural Bangladesh.Role of wireless capsule endoscopy in the follow-up of inflammatory bowel disease.Comparing the efficacy of a web-assisted calprotectin-based treatment algorithm (IBD-live) with usual practices in teenagers with inflammatory bowel disease: study protocol for a randomized controlled trialBiomarkers in inflammatory bowel disease: current practices and recent advances.Fecal Markers of Environmental Enteropathy are Associated with Animal Exposure and Caregiver Hygiene in BangladeshCorrelation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infectionFaecal calprotectin: factors affecting levels and its potential role as a surrogate marker for risk of development of Crohn's Disease.Use of blood based biomarkers in the evaluation of Crohn's disease and ulcerative colitis.Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study
P2860
Q24202614-F8A28D45-6E36-4B4F-9457-3BB92064B3A1Q24658606-7A9C23B5-85AB-495F-A4FE-F1794DC62B7DQ26766527-5BA87E44-C332-444A-A69F-A12225FE1DACQ26768273-1FC4A9E9-601D-40CB-A40B-C8BC43D7EEE4Q26776145-D91D5408-F940-424A-A3CC-8B03F5BD2B92Q26852795-49B8132B-4B2C-4549-80B7-E77F19E42EFEQ26996550-50A042AE-1BE3-4881-A887-7B6C746A4ADCQ27007083-A9B6E8ED-E2D0-4318-8616-6866524EF1A4Q28066449-890815A0-43AF-4CC4-B6CD-6B05E9F03C32Q28080934-89B9801C-E1AA-40FF-BAAB-CD15DD1663EFQ30275717-C4FDC90D-7EFD-4B17-A7A8-91B9EF70EFC1Q33613034-24009735-69C9-4AD1-B419-5E5A174C2815Q33648553-CD426A33-6537-4963-934A-F52237293711Q33648576-3FA77B8B-7471-4113-BAEA-522BD4E5F6BAQ33695598-D0C9A41F-3178-4F36-9427-10512D5AD943Q33746983-10121F31-79A8-4DD1-BB62-03F52FEAE481Q34021834-08C211FA-42DD-47CB-A400-A5AD2E9BD258Q34037058-1911F86C-B59A-4879-816E-9C75EE48B371Q34122878-33EFCFB0-B1FD-4122-9505-3888F6A84891Q34344472-F01E9F2A-444B-44CE-A192-12A26FFE1819Q34392076-3838293F-4277-4391-8B0E-E7D4B674ED4AQ34452588-7EC0588C-C1EC-4AD0-9692-87FDA075DFAAQ34456258-ACFB94D3-E7C5-4DA9-A941-6492C7D5B37FQ34464210-4E8F6830-D278-45C7-8CC5-03E914FF4962Q34576861-831BDA2B-B852-4C99-BF4D-0C7DEFAA7AB8Q34819062-0CB9FB6E-B41F-4006-B452-86C4C67F2360Q34937035-DEC78873-A6CC-4790-8A29-803E3B6F1E99Q35029903-42223F6E-4815-4B66-B2F5-A1F34A10F294Q35582808-74E369CE-5E44-4DFE-AD72-B7DF02244DC1Q35615098-9B02ABF4-BDA9-44CF-84B8-54056C644995Q35663887-8CD134AA-F6CB-49D4-8003-A579A18903B2Q35692459-5BD8AB65-A1E1-404F-88B4-DAA5A229E48FQ35709756-9D0E2539-89D6-4FE8-984C-0CBA55087661Q35801582-3994B7DA-65D6-4EBF-8C0E-E066F0E11EFCQ35840853-BD459B32-4942-443F-A867-398E81E6208BQ35933904-C87434CA-379F-40A4-8242-128CB6F285B8Q36059395-F4FEFFFF-7ADC-4B3D-AF92-D6BB3E77B012Q36157891-9F41F1BB-5DFB-4FEE-B7F7-9EEF5CE91A4FQ36316844-FF6D45C3-625F-45B3-B153-7ADF24C94291Q36449604-B30EB2F1-84FA-436C-9FE2-68ECD2C05F7C
P2860
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Faecal calprotectin for screen ...... ease: diagnostic meta-analysis
@ast
Faecal calprotectin for screen ...... ease: diagnostic meta-analysis
@en
Faecal calprotectin for screen ...... ease: diagnostic meta-analysis
@nl
type
label
Faecal calprotectin for screen ...... ease: diagnostic meta-analysis
@ast
Faecal calprotectin for screen ...... ease: diagnostic meta-analysis
@en
Faecal calprotectin for screen ...... ease: diagnostic meta-analysis
@nl
prefLabel
Faecal calprotectin for screen ...... ease: diagnostic meta-analysis
@ast
Faecal calprotectin for screen ...... ease: diagnostic meta-analysis
@en
Faecal calprotectin for screen ...... ease: diagnostic meta-analysis
@nl
P2860
P921
P3181
P356
P1433
P1476
Faecal calprotectin for screen ...... ease: diagnostic meta-analysis
@en
P2093
Els Van de Vijver
Vaclav Fidler
P2860
P3181
P356
10.1136/BMJ.C3369
P407
P433
P5008
P577
2010-07-15T00:00:00Z